Diagnostic Imaging Devices - South Africa

  • South Africa
  • The Diagnostic Imaging Devices market market in South Africa is forecasted to achieve a revenue of €275.40m in 2024.
  • This projection indicates a positive trend in the market's growth.
  • Moreover, it is expected that the market will exhibit a Compound Annual Growth Rate (CAGR) of 3.58% from 2024 to 2029, resulting in a market volume of €328.30m by 2029.
  • This demonstrates the potential for continued expansion within the industry.
  • However, when compared on a global scale, the United States is anticipated to generate the highest revenue of €11,060.00m in 2024.
  • The demand for advanced diagnostic imaging devices in South Africa is rapidly increasing due to the growing healthcare infrastructure and rising prevalence of chronic diseases.

Key regions: Germany, Japan, Netherlands, Spain, United States

 
Mercado
 
Región
 
Comparación de regiones
 
Moneda
 

Analyst Opinion

The Diagnostic Imaging Devices market in South Africa has been experiencing steady growth in recent years, driven by customer preferences for advanced medical imaging technologies and the increasing demand for early and accurate diagnosis of medical conditions. Customer preferences in the Diagnostic Imaging Devices market in South Africa are largely influenced by global trends. Customers are increasingly seeking imaging devices that offer high image resolution, faster scanning times, and improved patient comfort. This is driving the demand for advanced technologies such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound devices. Additionally, there is a growing preference for portable and handheld imaging devices, particularly in rural areas where access to healthcare facilities is limited. The market is also witnessing a shift towards digital imaging technologies, as customers seek more efficient and cost-effective solutions. Digital imaging allows for easier storage, retrieval, and sharing of medical images, improving workflow efficiency and patient care. This trend is expected to continue driving the demand for digital radiography (DR) and picture archiving and communication systems (PACS). Local special circumstances in South Africa also play a role in the development of the Diagnostic Imaging Devices market. The country has a high burden of disease, with a significant prevalence of conditions such as HIV/AIDS, tuberculosis, and cardiovascular diseases. This has led to an increased need for diagnostic imaging devices for early detection and monitoring of these conditions. Additionally, the government has been investing in the development of healthcare infrastructure, including the establishment of new hospitals and clinics in underserved areas. This has created opportunities for the expansion of the Diagnostic Imaging Devices market in these regions. Underlying macroeconomic factors, such as population growth and increasing healthcare expenditure, are driving the growth of the Diagnostic Imaging Devices market in South Africa. The country has a growing population, which is contributing to the increasing demand for healthcare services. Furthermore, the government has been increasing its healthcare budget to improve access to quality healthcare services. This has resulted in increased investment in medical equipment, including diagnostic imaging devices. In conclusion, the Diagnostic Imaging Devices market in South Africa is developing in response to customer preferences for advanced imaging technologies, the shift towards digital imaging, local special circumstances such as a high burden of disease, and underlying macroeconomic factors such as population growth and increased healthcare expenditure. These factors are expected to continue driving the growth of the market in the coming years.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Visión general

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Espere, por favor

Contacto

¿Alguna duda? Estaremos encantados de atenderte.
Statista Locations
Contacto Nerea Marcos
Nerea Marcos
Client Success Manager

Lu - vi, 9:30 - 17:00 h (CET)

Contacto Meredith Alda
Meredith Alda
Sales Manager– Contacto (Estados Unidos)

Lu - vi, 9:00 - 18:00 h (EST)

Contacto Yolanda Mega
Yolanda Mega
Operations Manager– Contacto (Asia)

Lu - vi, 9:00 - 17:00 h (SGT)

Contacto Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contacto (Asia)

Lu - vi, 10:00 - 18:00 h (JST)

Contacto Lodovica Biagi
Lodovica Biagi
Director of Operations– Contacto (Europa)

Lu - vi, 9:30 - 17:00 h (GMT)

Contacto Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contacto (América Latina)

Lu - vi, 9:00am-6:00pm (EST)